Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
23
datasets available to search
ShareScore release 0.9.0
Dataset results
23 results for “Metreleptin”
Study to Examine Safety, Tolerability, and Effect on Body Weight of Metreleptin Administered in Conjunction With Pramlintide in Obese and Overweight Subjects
ClinicalTrials.gov study NCT00673387. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy
ClinicalTrials.gov study NCT01679197. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Effects of Metreleptin in Type 1 Diabetes Mellitus
ClinicalTrials.gov study NCT01268644. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Effect of Metreleptin Therapy in the Treatment of Severe Insulin Resistance
ClinicalTrials.gov study NCT00085982. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Extension Study of Protocol DFA102 to Examine the Long-Term Safety, Tolerability, and Effect on Body Weight of Pramlintide Administered in Combination With Metreleptin
ClinicalTrials.gov study NCT00819234. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy
ClinicalTrials.gov study NCT02262832. IPD Sharing: NO. Countries: 1. Publications: 3.
An Open-Label Treatment Protocol to Provide Metreleptin for the Treatment of Diabetes Mellitus and/or Hypertriglyceridemia Associated With Lipodystrophy
ClinicalTrials.gov study NCT00677313. IPD Sharing: Not stated. Countries: 1. Publications: 4.
MEASuRE: Metreleptin Effectiveness And Safety Registry
ClinicalTrials.gov study NCT02325674. IPD Sharing: Not stated. Countries: 5. Publications: 1.
Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy
ClinicalTrials.gov study NCT02262806. IPD Sharing: NO. Countries: 1. Publications: 3.
A Study To Examine The Efficacy And Safety Of Pramlintide+Metreleptin In Obese Subjects
ClinicalTrials.gov study NCT01235741. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of the Safety of Mibavademab in Pediatric and Adult Participants Switching From Metreleptin to Mibavademab for the Treatment of Generalized Lipodystrophy (GLD)
ClinicalTrials.gov study NCT06548100. IPD Sharing: YES. Countries: 1. Publications: 0.
Immunogenicity of Metreleptin in Patients With Generalized Lipodystrophy
ClinicalTrials.gov study NCT04026178. IPD Sharing: YES. Countries: 1. Publications: 0.
CLINICAL PROTOCOL to Investigate the Long-term Safety and Efficacy of Metreleptin in Various Forms of Partial Lipodystrophy
ClinicalTrials.gov study NCT02654977. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of Safety and Efficiency of Metreleptin Treatment for Patients With Multiple Symmetric Lipomatosis (MSL)
ClinicalTrials.gov study NCT05351164. IPD Sharing: NO. Countries: 1. Publications: 0.
Open-label Study to Evaluate Metreleptin in Children Under 6 Years of Age With Generalised Lipodystrophy
ClinicalTrials.gov study NCT06502990. IPD Sharing: Not stated. Countries: 4. Publications: 0.
The Effects of Metreleptin in Congenital Leptin Deficiency
ClinicalTrials.gov study NCT04063488. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Metreleptin in Anorexia Nervosa
ClinicalTrials.gov study NCT06305182. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Open-label Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy
ClinicalTrials.gov study NCT06484868. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Natural History of Pregnancy and Pregnancy Outcomes in Metreleptin-Treated vs Untreated Subjects With Lipodystrophy
ClinicalTrials.gov study NCT05419037. IPD Sharing: NO. Countries: 1. Publications: 0.
Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy
ClinicalTrials.gov study NCT06679270. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.